small single-arm phase II studies to evaluate the potential clinical benefit of induction chemotherapy followed by surgical resection. In addition, several retrospective reviews of institutional data, and analyses of national cancer databases, together
Search Results
Surgery for Early-Stage Small Cell Lung Cancer
Bryan J. Schneider, Ashish Saxena, and Robert J. Downey
University of Michigan Comprehensive Cancer Center Opportunities for Improvement Project
Tara M. Breslin, Marcy Waldinger, and Samuel M. Silver
Care Center. The UMCCC Breast Care Center was started in 1985, and it was the first academic multidisciplinary breast care clinic. The UMCCC project involved 3 broad goals. The first was to perform an in-depth chart review of each discordant case to
BIO19-022: Reducing Patient Waiting Times for Treatment Decision Making, Helps in Improving the Treatment Planning Process
Naresh Ramarajan, Farzana Begum, and Gitika Srivastava
or more to get an online expert review from leading cancer hospitals in the United States and in India. Such delays have an important psychosocial impact on the patient and caregivers. Patients worldwide often race to start treatments at non
Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors
Laura C. Kennedy, Shailender Bhatia, John A. Thompson, and Petros Grivas
of irAEs could convert a number of patients to objective responders. 7 It is not clear, however, that this translates to all tumor types treated with ICIs. This article reviews the application of ICI therapy to patients with solid tumors and
Four-Year Disease-Free Remission in a Patient With POLE Mutation–Associated Colorectal Cancer Treated Using Anti–PD-1 Therapy
Michael L. Durando, Sanjay V. Menghani, Jessica L. Baumann, Danny G. Robles, Tovah A. Day, Cyrus Vaziri, and Aaron J. Scott
remained disease-free 48 months after the first pembrolizumab infusion and was transitioned to annual surveillance follow-up in the clinic. Figure 4. CEA level over time, indicating important events (ie, treatment day, scan review) along the disease
Interdigitating Dendritic Cell Sarcoma
Venkata K. Pokuri, Mihai Merzianu, Shipra Gandhi, Junaid Baqai, Thom R. Loree, and Seema Bhat
journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/60900 ; and 4) view
Principles and Techniques of Radiation Therapy for Esophageal and Gastroesophageal Junction Cancers
Lisa Hazard, Gary Yang, Mary Frances McAleer, James Hayman, and Christopher Willett
M Bossuyt PM . Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer . J Clin Oncol 2004 ; 22 : 3805 – 3812 . 6. DeYoung C Suntharalingam M Line BR . The ability of
Surgery in the Management of Small Cell Lung Cancer
Robert J. Downey and Lee M. Krug
-celled carcinoma of the bronchus: Ten-year follow-up . Lancet 1973 ; 2 : 63 – 65 . 9 Deslauriers J . Surgery for small cell lung cancer . [Review] Lung Cancer 1997 ; 17 ( Suppl 1 ): S91 – S98 . 10 Prasad US Naylor AR Walker WS . Long
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
Gregory P. Kalemkerian, Billy W. Loo Jr, Wallace Akerley, Albert Attia, Michael Bassetti, Yanis Boumber, Roy Decker, M. Chris Dobelbower, Afshin Dowlati, Robert J. Downey, Charles Florsheim, Apar Kishor P. Ganti, John C. Grecula, Matthew A. Gubens, Christine L. Hann, James A. Hayman, Rebecca Suk Heist, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian Molina, Cesar A. Moran, Daniel Morgensztern, Saraswati Pokharel, David C. Portnoy, Deborah Rhodes, Chad Rusthoven, Jacob Sands, Rafael Santana-Davila, Charles C. Williams Jr, Karin G. Hoffmann, and Miranda Hughes
certificate of participation. To participate in this journal CE activity: 1) review the educational content; 2) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/84150 ; and 3) view
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Patricia Aoun, Philippe Armand, Celeste M. Bello, Cecil M. Benitez, Philip J. Bierman, Robert Chen, Bouthaina Dabaja, Robert Dean, Andres Forero, Leo I. Gordon, Francisco J. Hernandez-Ilizaliturri, Ephraim P. Hochberg, Jiayi Huang, Patrick B. Johnston, Mark S. Kaminski, Vaishalee P. Kenkre, Nadia Khan, Kami Maddocks, David G. Maloney, Monika Metzger, Joseph O. Moore, David Morgan, Craig H. Moskowitz, Carolyn Mulroney, Rachel Rabinovitch, Stuart Seropian, Randa Tao, Jane N. Winter, Joachim Yahalom, Jennifer L. Burns, and Ndiya Ogba
activity will be issued a certificate of participation. To participate in this journal CE activity: 1) review the educational content; 2) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/82684
